| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $68.6M | -7.6% |
| Cost of Revenue | $26K | -96.9% |
| R&D Expense | $456.0M | -10.0% |
| SG&A Expense | $92.1M | -22.6% |
| Operating Income | -$479.3M | +18.4% |
| Pre-tax Income | -$437.8M | +16.3% |
| Income Tax | $217K | +119.0% |
| Net Income | -$438.0M | +16.1% |
| EPS (Basic) | -$3.16 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.2M | +4.1% |
| Short-term Investments | $228.8M | -66.3% |
| Current Assets | $514.1M | -50.7% |
| Total Assets | $1.00B | -28.3% |
| Current Liabilities | $92.8M | -22.4% |
| Total Liabilities | $237.5M | -4.4% |
| Stockholders' Equity | $765.3M | -33.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$391.8M | +12.2% |
| Capital Expenditures | $4.8M | -33.8% |
| Investing Cash Flow | $310.4M | -37.8% |
| Financing Cash Flow | $3.8M | -13.7% |
| Free Cash Flow | -$396.6M | +12.6% |
| +17.5% |
| EPS (Diluted) | -$3.16 | +17.5% |